Organ transplantation has become an established therapy in patients suffering from diseases leading to organ failure. Table I shows the number of organ transplants performed in the Eurotransplant area from 1 g90 to 1993. The use of potent immunosuppressive drugs and effective protocols for prevention and treatment of infectious diseases have contributed to improved outcome of clinical organ transplantation. Nowadays, one-year patient and graft survival after kidney transplantation is 85 to 95 % (1). However, the potent immune response to transplanted tissues leading to acute graft rejection remains a major problem.

T lymfocites, cytokines, immunology, organ transplantation
R. Benner (Robbert)
Erasmus University Rotterdam
Dutch Kidney Foundation,
978-90-73436-21-3
hdl.handle.net/1765/21468
Erasmus MC: University Medical Center Rotterdam

Vossen, A.C.Th.M. (1995, March 8). Cytokines and T lymphocytes in transplantation : targets for immunotherapy. Erasmus University Rotterdam. Retrieved from http://hdl.handle.net/1765/21468